Back to results
US 2008/0176827 A1Published application
New Pyridine Analogues VII 543
AssigneeAstraZeneca AB
InventorsThomas Antonsson, Peter Bach, Kay Brickmann, Ruth Bylund, Fabrizio Giordanetto, Johan Johansson, Fredrik Zetterberg
Life of this patent
Estimating the term…
Abstract
The present invention relates to certain new pyridin analogues of Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
Claims23
A compound of formula I or a pharmaceutically acceptable salt thereof:
- wherein
- R1 represents R6OC(O);
- R2 represents methyl, ethyl or methylamino;
- R6 represents ethyl or halogenated ethyl;
- R14 represents H, (C1-C12)alkyl optionally interrupted by oxygen and/or optionally substituted by one or more of OH, COOH and COORe;
- wherein Re represents aryl, cycloalkyl, heterocyclyl or (C1-C12)alkyl optionally substituted by one or more of halogen atoms, OH, aryl, cycloalkyl and heterocyclyl;
- Rc represents methylene (—CH2—) or ethylene (—CH2—CH2—);
- Rd represents phenyl, wherein the phenyl group optionally;
- is
- substituted by one or more fluorine atom(s), and/or
- substituted by one or more chlorine atom(s) only in one or more of the 2, 4, 5, 6-positions of the phenyl ring, and/or
- mono-, tri-, tetra- or penta-substituted by methyl group(s), and/or
- substituted by one or more methoxy group(s) only in one or more of the 2, 3, 5, 6-positions of the phenyl ring;
- X represents a single bond or methylene (—CH2—), wherein the methylene group may optionally be substituted with (C1-C6) alkyl;
- or
- X represents a group (—CH2—)n wherein n=2-6, which optionally is unsaturated and/or substituted by one or more substituent selected from halogen, hydroxyl or (C1-C6)alkyl;
- B is a ring/ring system comprising a nitrogen which nitrogen is connected to the pyridine-ring (according to formula I) and the B-ring/ring system is connected to X in another of its positions, wherein the substituent R14 is connected to the B ring/ring system in such a way that no quarternary ammonium compounds are formed (by this connection), and wherein the B ring/ring system is selected from 3-azetidin-1-ylene, 3-pyrrolidine-1-ylene and 4-piperidine-1-ylene;
- and
- wherein the following compounds are not included:
- ethyl 6-[3-({[(2-chlorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-5-cyano-2-methylnicotinate
- ethyl 6-[3-({[(4-chlorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-5-cyano-2-methylnicotinate
- ethyl 5-cyano-6-[3-({[(3-fluorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-[3-({[(2-phenylethyl)sulfonyl]amino}carbonyl)azetidin-1-yl]nicotinate
- ethyl 5-cyano-2-methyl-6-[3-({[(2-methylbenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]nicotinate
- ethyl 5-cyano-6-{3-[({[2-(4-fluorophenyl)ethyl]sulfonyl}amino)carbonyl]azetidin-1-yl}-2-methylnicotinate
- ethyl 5-cyano-6-[3-({[(4-fluorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-6-{3-[({[2-(2-fluorophenyl)ethyl]sulfonyl}amino)carbonyl]azetidin-1-yl}-2-methylnicotinate
- ethyl 5-cyano-6-{3-[({[2-(3-fluorophenyl)ethyl]sulfonyl}amino)carbonyl]azetidin-1-yl}-2-methylnicotinate
- ethyl 6-(4-{[(benzylsulfonyl)amino]carbonyl}-4-methylpiperidin-1-yl)-5-cyano-2-methylnicotinate
- ethyl 6-(4-{[(benzylsulfonyl)amino]carbonyl}piperidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 6-[4-({[(4-chlorobenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]-5-cyano-2-methylnicotinate
- ethyl 6-(4-{[(benzylsulfonyl)amino]carbonyl}piperidin-1-yl)-5-cyano-2-methylnicotinate
- ethyl 6-(3-{[(benzylsulfonyl)amino]carbonyl}azetidin-1-yl)-5-cyano-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-[3-({[(3-methylbenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]nicotinate
- ethyl 5-cyano-2-methyl-6-[3-({[(4-methylbenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]nicotinate
- ethyl 5-cyano-6-[4-({[(4-fluorobenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]-2-methylnicotinate
- 2,2,2-trifluoroethyl 6-(4-{[(benzylsulfonyl)amino]carbonyl}piperidin-1-yl)-5-cyano-2-methylnicotinate
- 2,2,2-trifluoroethyl 6-(3-{[(benzylsulfonyl)amino]carbonyl}azetidin-1-yl)-5-cyano-2-methylnicotinate
- 2,2,2-trifluoroethyl 6-[3-({[(4-chlorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-5-cyano-2-methylnicotinate
- ethyl 6-(3-{[(benzylsulfonyl)amino]carbonyl}azetidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-2-methyl-6-[4-({[(4-methylbenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]nicotinate
- ethyl 5-cyano-6-[4-({[(3-fluorobenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-[4-({[(2-phenylethyl)sulfonyl]amino}carbonyl)piperidin-1-yl]nicotinate
- ethyl 6-(3-{2-[(benzylsulfonyl)amino]-2-oxoethyl}azetidin-1-yl)-5-cyano-2-methylnicotinate
- ethyl 5-cyano-6-[3-(2-{[(4-fluorobenzyl)sulfonyl]amino}-2-oxoethyl)azetidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-6-[4-({[(3-fluoro-4-methylbenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-6-[3-({[(3,4-difluorobenzyl)sulfonyl]amino}carbonyl)azetidin-1-yl]-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-[4-({[(3-methylbenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]nicotinate and
- ethyl 5-cyano-6-[4-({[(3,4-difluorobenzyl)sulfonyl]amino}carbonyl)piperidin-1-yl]-2-methylnicotinate.
46 more elements
A compound selected from:
- ethyl 6-(3-{2-[(benzylsulfonyl)amino]-2-oxoethyl}pyrrolidin-1-yl)-5-cyano-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-[3-(2-oxo-2-{[(2-phenylethyl)sulfonyl]amino}ethyl)pyrrolidin-1-yl]nicotinate
- 2,2,2-trifluoroethyl 5-cyano-6-(4-{[(4-fluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(3-{[(2-fluoro-5-methylbenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-2-methylnicotinate
- ethyl 6-{4-[(benzylsulfonyl)carbamoyl]-3-methylpiperidin-1-yl}-5-cyano-2-methylnicotinate
- ethyl 6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-(methylamino)nicotinate
- ethyl 5-cyano-6-(4-{[(2-fluoro-5-methylbenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(4-{[(3-methoxybenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(3-{[(2,6-difluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-2-ethylnicotinate
- ethyl 5-cyano-2-ethyl-6-(3-{[(4-fluoro-3-methylbenzyl)sulfonyl]carbamoyl}azetidin-1-yl)nicotinate
- ethyl 6-(3-{[(2-chloro-4-fluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-6-(4-{[(5-fluoro-2-methylbenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-2-methyl-6-(4-{[(2,3,6-trifluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)nicotinate
- ethyl 5-cyano-6-(4-{[(2,4-difluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(4-{[(2,6-difluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-ethylnicotinate
- ethyl 6-(4-{[(2-chloro-4-fluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-2-ethyl-6-(4-{[(2,3,6-trifluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)nicotinate
- ethyl 5-cyano-6-(4-{[(2,4-difluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-ethylnicotinate
- ethyl 6-(4-{[(4-chloro-2-fluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-6-(3-{[(2,4-difluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(3-{[(2,4-difluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-2-ethylnicotinate
- ethyl 5-cyano-2-ethyl-6-(3-{[(4-fluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)nicotinate
- ethyl 6-(3-{[(4-chlorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-2-ethyl-6-(4-{[(4-fluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)nicotinate
- ethyl 6-(4-{[(4-chlorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-5-cyano-2-ethylnicotinate
- ethyl 5-cyano-6-(3-{[(2-fluorobenzyl)sulfonyl]carbamoyl}azetidin-1-yl)-2-methylnicotinate
- ethyl 5-cyano-6-(4-{[(2-fluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-2-methylnicotinate
- ethyl 6-{3-[3-(benzyloxy)-3-oxopropyl]-4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methylnicotinate
- ethyl 6-(3-[3-(benzyloxy)-3-oxopropyl]-4-{[(2,4-difluorobenzyl)sulfonyl]carbamoyl}piperidin-1-yl)-5-cyano-2-methylnicotinate and
- 3-{4-[(benzylsulfonyl)carbamoyl]-1-[3-cyano-5-(ethoxycarbonyl)-6-methylpyridin-2-yl]piperidin-3-yl}propanoic acid;
- or a pharmaceutically acceptable salt thereof
28 more elements
22-24. (canceled)
Dependencies are inferred from the claim text.